Biogen, Inc. (BIIB)
175.84
-4.60
(-2.55%)
USD |
NASDAQ |
Dec 09, 16:00
175.25
-0.59
(-0.34%)
After-Hours: 20:00
Biogen EPS Diluted (Quarterly): 3.171 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Eli Lilly & Co. | 6.211 |
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
| Stoke Therapeutics, Inc. | -0.6543 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 466.50M |
| Revenue (Quarterly) | 2.455B |
| Total Expenses (Quarterly) | 1.988B |
| Enterprise Value | 28.43B |
| Gross Profit Margin (Quarterly) | 64.29% |
| Profit Margin (Quarterly) | 19.00% |
| Earnings Yield | 6.24% |
| Operating Earnings Yield | 9.46% |
| Normalized Earnings Yield | 7.034 |